Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Beraprost Sodium on Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy (BESTinDN Study)

NCT01796418 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01796418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01796418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Beraprost Sodium on Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy (BESTinDN Study)
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2013
Completion date
Not reported
Enrollment
102 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathy